158.71
Precedente Chiudi:
$158.58
Aprire:
$157.84
Volume 24 ore:
2.09M
Relative Volume:
0.92
Capitalizzazione di mercato:
$27.64B
Reddito:
$15.50B
Utile/perdita netta:
$1.33B
Rapporto P/E:
21.62
EPS:
7.34
Flusso di cassa netto:
$2.16B
1 W Prestazione:
+2.65%
1M Prestazione:
+15.85%
6M Prestazione:
-20.64%
1 anno Prestazione:
-24.93%
Iqvia Holdings Inc Stock (IQV) Company Profile
Nome
Iqvia Holdings Inc
Settore
Industria
Telefono
919-998-2000
Indirizzo
2400 ELLIS ROAD, DURHAM, NC
Confronta IQV con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
IQV
Iqvia Holdings Inc
|
158.71 | 27.64B | 15.50B | 1.33B | 2.16B | 7.34 |
![]()
TMO
Thermo Fisher Scientific Inc
|
410.65 | 156.49B | 42.90B | 6.52B | 6.72B | 17.05 |
![]()
DHR
Danaher Corp
|
201.00 | 145.01B | 23.82B | 3.77B | 4.90B | 5.15 |
![]()
IDXX
Idexx Laboratories Inc
|
530.40 | 42.30B | 3.93B | 894.97M | 837.70M | 10.82 |
![]()
A
Agilent Technologies Inc
|
118.62 | 34.24B | 6.63B | 1.17B | 1.19B | 4.05 |
Iqvia Holdings Inc Stock (IQV) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2025-04-25 | Downgrade | HSBC Securities | Buy → Hold |
2025-04-10 | Downgrade | Barclays | Overweight → Equal Weight |
2025-02-03 | Downgrade | BTIG Research | Buy → Neutral |
2024-12-20 | Iniziato | Stephens | Overweight |
2024-10-14 | Iniziato | Redburn Atlantic | Buy |
2024-09-04 | Iniziato | RBC Capital Mkts | Outperform |
2024-07-24 | Downgrade | Jefferies | Buy → Hold |
2024-06-06 | Iniziato | Goldman | Buy |
2024-02-26 | Iniziato | Leerink Partners | Outperform |
2024-02-15 | Downgrade | Guggenheim | Buy → Neutral |
2024-02-13 | Iniziato | BTIG Research | Buy |
2023-11-02 | Downgrade | Robert W. Baird | Outperform → Neutral |
2023-09-06 | Iniziato | HSBC Securities | Buy |
2023-03-17 | Iniziato | Truist | Buy |
2022-12-06 | Iniziato | Cowen | Outperform |
2022-11-17 | Downgrade | Citigroup | Buy → Neutral |
2022-08-25 | Iniziato | Credit Suisse | Outperform |
2022-07-15 | Iniziato | SVB Leerink | Outperform |
2022-05-24 | Iniziato | Guggenheim | Buy |
2022-04-29 | Aggiornamento | Piper Sandler | Neutral → Overweight |
2022-04-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
2021-08-05 | Ripresa | Credit Suisse | Outperform |
2021-04-16 | Aggiornamento | Stephens | Equal-Weight → Overweight |
2021-03-08 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
2021-03-03 | Iniziato | Barclays | Overweight |
2020-07-07 | Iniziato | Stephens | Equal-Weight |
2020-03-02 | Iniziato | Deutsche Bank | Buy |
2020-01-08 | Iniziato | Wells Fargo | Overweight |
2020-01-07 | Iniziato | Citigroup | Buy |
2019-12-13 | Aggiornamento | CFRA | Sell → Hold |
2019-11-14 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
2019-06-21 | Aggiornamento | Mizuho | Neutral → Buy |
2019-05-28 | Iniziato | SVB Leerink | Outperform |
2019-01-18 | Aggiornamento | Jefferies | Hold → Buy |
2018-10-09 | Iniziato | UBS | Buy |
2018-10-02 | Reiterato | Robert W. Baird | Outperform |
2018-07-25 | Aggiornamento | BofA/Merrill | Neutral → Buy |
2018-07-25 | Reiterato | Stifel | Buy |
2018-07-03 | Aggiornamento | Raymond James | Outperform → Strong Buy |
2018-04-13 | Aggiornamento | Goldman | Neutral → Buy |
2018-03-07 | Aggiornamento | SunTrust | Hold → Buy |
2018-01-19 | Iniziato | Evercore ISI | Outperform |
Mostra tutto
Iqvia Holdings Inc Borsa (IQV) Ultime notizie
Baird Adjusts Price Target on IQVIA Holdings to $159 From $161, Maintains Neutral Rating - MarketScreener
Drug Development Inputs & Services Stocks Q1 Highlights: IQVIA (NYSE:IQV) - Yahoo Finance
IQVIA Holdings Stock: Is IQV Underperforming the Healthcare Sector? - MSN
IQVIA Health Research Space Wins 2025 MedTech Breakthrough Award for ‘Best Mobile App for Patient Engagement’ - Business Wire
Learn to Evaluate (IQV) using the Charts - news.stocktradersdaily.com
Park Avenue Securities LLC Grows Stock Position in IQVIA Holdings Inc. (NYSE:IQV) - Defense World
IQVIA Completes $2 Billion Senior Notes Offering - Global Legal Chronicle
Nvidia Just Partnered With A Weight-Loss Giant, But It's Not About Pills - Benzinga
IQVIA unveils AI agents for life sciences using NVIDIA technology By Investing.com - Investing.com South Africa
IQVIA Holdings Inc. stock outperforms competitors on strong trading day - MSN
IQVIA Launches New AI Agents for Life Sciences and Healthcare - MarketScreener
IQVIA unveils AI agents for life sciences using NVIDIA technology - Investing.com
IQVIA Holdings Stock: Is IQV Underperforming The Healthcare Sector? - Barchart.com
IQVIA Stock: Stuck In A Time SpiralValue Play Or Bull Trap? - Benzinga
IQVIA Holdings (NYSE:IQV) Sees 11% Share Price Rise Over Last Week - Yahoo Finance
IQVIA Holdings Inc (IQV) Trading 3.9% Higher on Jun 10 - GuruFocus
IQVIA Holdings (IQV) Leads S&P 500 Healthcare Gainers - GuruFocus
IQVIA Holdings Issues $2 Billion in Senior Notes - TipRanks
IQVIA Holdings Inc (IQV) Trading 3.85% Higher on Jun 4 - GuruFocus
IQVIA to raise $2B via senior notes offering to repay debt - MSN
IQVIA announces pricing of senior notes - MSN
IQVIA prices $2 billion senior notes offering By Investing.com - Investing.com South Africa
IQVIA Holdings Inc. (IQV) Announces $2 Billion Senior Notes Offe - GuruFocus
Rep. Robert Bresnahan, Jr. Sells Off Shares of IQVIA Holdings Inc. (NYSE:IQV) - Defense World
IQVIA Announces Pricing of Senior Notes - 01net
IQVIA Inc. (IQV) Secures $2 Billion in Senior Notes Offering - GuruFocus
IQVIA Holdings Announces $2 Billion Senior Notes Offering - TipRanks
IQVIA Announces Pricing of Senior Notes | IQV Stock News - GuruFocus
IQVIA Prices $2 Billion Senior Notes Due 2032 - marketscreener.com
IQVIA Announces Pricing Of Senior Notes - marketscreener.com
IQVIA prices $2 billion senior notes offering - Investing.com Australia
IQVIA announces offering of senior notes - IQVIA
IQVIA Announces Offering of Senior Notes - BioSpace
Iqvia Plans $2 Billion Notes Offering - marketscreener.com
IQVIA Announces Offering of Senior Notes | IQV Stock News - GuruFocus
IQVIA plans $2 billion senior notes offering by 2032 - Investing.com
Iqvia Announces Offering Of Senior Notes - marketscreener.com
IQVIA Holdings Inc. (NYSE:IQV) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
What is Zacks Research’s Forecast for IQVIA Q2 Earnings? - Defense World
IQVIA Holdings Inc (IQV) Trading 3.28% Higher on May 27 - GuruFocus
IQVIA Holdings Inc. Announces First Patient Dosed in Renew Phase 2 Trial of Lti-03 in Patients with Ipf - marketscreener.com
IQV Collaborates with Rein Therapeutics on New IPF Trial | IQV S - GuruFocus
IQV Collaborates with Rein Therapeutics on New IPF Trial | IQV Stock News - GuruFocus
Rein Therapeutics Announces First Patient Dosed in RENEW Phase 2 Trial of LTI-03 in Patients with IPF - marketscreener.com
Iqvia Holdings Inc Azioni (IQV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Iqvia Holdings Inc Azioni (IQV) insider trading
Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
---|---|---|---|---|---|---|---|
DANHAKL JOHN G | Director |
Dec 03 '24 |
Buy |
200.58 |
1,275 |
255,740 |
1,275 |
Sherbet Eric | See Remarks |
Aug 27 '24 |
Sale |
246.33 |
1,300 |
320,229 |
19,536 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):